{"id":"https://openalex.org/W3112909267","doi":"https://doi.org/10.1093/neuonc/noaa215.597","title":"NCOG-59. PROGRESSION-FREE SURVIVAL AS A PRIMARY OUTCOME MEASURE TO COMPARE CONSOLIDATIVE STRATEGIES IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA","display_name":"NCOG-59. PROGRESSION-FREE SURVIVAL AS A PRIMARY OUTCOME MEASURE TO COMPARE CONSOLIDATIVE STRATEGIES IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA","publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3112909267","doi":"https://doi.org/10.1093/neuonc/noaa215.597","mag":"3112909267"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noaa215.597","doi":"https://doi.org/10.1093/neuonc/noaa215.597","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa215.597","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/Supplement_2/ii142/34691002/noaa215.597.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/Supplement_2/ii142/34691002/noaa215.597.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029680230","display_name":"Alipi V. Bonm","orcid":"https://orcid.org/0000-0003-0340-2008","observed_orcids":["https://orcid.org/0000-0003-0340-2008","https://orcid.org/0009-0005-6637-0279"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alipi Bonm","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062423628","display_name":"Alec W. Gibson","orcid":"https://orcid.org/0000-0002-5709-4146","observed_orcids":["https://orcid.org/0000-0002-5709-4146"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alec Gibson","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102768591","display_name":"Leona A. Holmberg","orcid":"https://orcid.org/0000-0002-2803-0469","observed_orcids":["https://orcid.org/0000-0002-2803-0469"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leona Holmberg","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008500773","display_name":"Marco Mielcarec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Mielcarec","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001529371","display_name":"Tresa Michelle McGranahan","orcid":"https://orcid.org/0000-0003-0472-4252","observed_orcids":["https://orcid.org/0000-0003-0472-4252"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tresa McGranahan","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073677500","display_name":"Lynne Patricia Taylor","orcid":"https://orcid.org/0000-0001-5946-3796","observed_orcids":["https://orcid.org/0000-0001-5946-3796"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynne Taylor","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036417448","display_name":"Jerome J. Graber","orcid":"https://orcid.org/0000-0001-5357-2932","observed_orcids":["https://orcid.org/0000-0001-5357-2932"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerome Graber","raw_affiliation_strings":["University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"Supplement_2","first_page":"ii142","last_page":"ii142"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.871999979019165},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.9340000152587891},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.871999979019165},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8159999847412109},{"id":"https://openalex.org/keywords/age-as-confounder","display_name":"age as confounder","score":0.5659999847412109},{"id":"https://openalex.org/keywords/reinduction-therapy","display_name":"reinduction therapy","score":0.6980000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7062760591506958},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.651071310043335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6319408416748047},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5805708169937134},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5363963842391968},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.531495988368988},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4281958043575287},{"id":"https://openalex.org/C2781173314","wikidata":"https://www.wikidata.org/wiki/Q3246818","display_name":"Primary central nervous system lymphoma","level":3,"score":0.41671156883239746},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4158034324645996},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3353521227836609},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.1187204122543335},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/neuonc/noaa215.597","doi":"https://doi.org/10.1093/neuonc/noaa215.597","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa215.597","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/Supplement_2/ii142/34691002/noaa215.597.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7461422","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7651611","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7651611","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7651611","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noaa215.597","doi":"https://doi.org/10.1093/neuonc/noaa215.597","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noaa215.597","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/22/Supplement_2/ii142/34691002/noaa215.597.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3112909267.pdf","grobid_xml":"https://content.openalex.org/works/W3112909267.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3119108778","https://openalex.org/W4406254622","https://openalex.org/W2986621104","https://openalex.org/W4400018518","https://openalex.org/W2294816409","https://openalex.org/W2055926684","https://openalex.org/W2095842949","https://openalex.org/W6902392142","https://openalex.org/W7093081260","https://openalex.org/W7128170270"],"abstract_inverted_index":{"Abstract":[0],"Relapsed":[1],"or":[2,114,129],"refractory":[3],"primary":[4],"CNS":[5,47],"non-Hodgkin\u2019s":[6],"lymphoma":[7,48],"(rrPCNSL)":[8],"is":[9,19,212,222],"a":[10,26,53,93,213,236],"rare":[11],"and":[12,45,66,146,182,197,221],"challenging":[13],"malignancy":[14],"for":[15,177,185,216],"which":[16,218],"better":[17],"evidence":[18],"needed":[20],"to":[21,155,238],"guide":[22],"management.":[23],"We":[24,208],"present":[25],"retrospective":[27],"cohort":[28],"of":[29,39,56,77,89,96,122,144,169,201],"70":[30,99],"consecutive":[31],"patients":[32,49,152,190],"with":[33,133,160,174,225],"rrPCNSL":[34,217],"treated":[35],"at":[36],"the":[37,198],"University":[38],"Washington":[40],"between":[41,205],"2000-2020.":[42],"HIV":[43],"positive":[44],"secondary":[46],"were":[50,193,203],"excluded.":[51],"During":[52],"median":[54,59,67,147,167,199],"follow-up":[55],"19.8":[57],"months,":[58],"overall":[60,140],"survival":[61,69],"(OS)":[62],"was":[63,71,85,92,119],"18.30":[64],"months":[65,171,176,184],"progression-free":[68],"(PFS)":[70],"12.67":[72],"months.":[73,150],"At":[74],"all":[75],"stages":[76],"disease":[78],"(diagnosis,":[79],"first":[80,112],"relapse,":[81],"multiple":[82],"relapses),":[83],"PFS":[84,101,110,148,168,211,228],"an":[86,139,230],"excellent":[87],"predictor":[88],"OS.":[90],"There":[91,118],"small":[94],"effect":[95,108,121],"age":[97,123],"<":[98,124],"on":[100,109,126],"after":[102,111],"initial":[103],"diagnosis":[104],"(PFS1),":[105],"but":[106],"no":[107,120,186],"(PFS2)":[113],"subsequent":[115],"(PFS3+)":[116],"relapses.":[117],"60":[125],"PFS1,":[127],"PFS2,":[128],"PFS3+.":[130],"Patients":[131],"reinduced":[132],"high-dose":[134],"methotrexate-based":[135],"(HD-MTX)":[136],"regimens":[137],"had":[138,166],"response":[141],"rate":[142],"(ORR)":[143],"86.7%":[145],"17.2":[149],"For":[151],"who":[153],"responded":[154],"reinduction":[156],"therapy,":[157],"those":[158],"consolidated":[159],"autologous":[161],"stem":[162],"cell":[163],"transplant":[164],"(ASCT)":[165],"30.3":[170],"(n=11)":[172],"compared":[173],"12.1":[175],"other":[178,242],"consolidation":[179,187,206,240],"strategies":[180],"(n=9),":[181],"9.0":[183],"(n=20).":[188],"Although":[189],"receiving":[191],"ASCT":[192],"younger,":[194],"KPS,":[195],"sex,":[196],"number":[200],"recurrences":[202],"similar":[204],"groups.":[207],"conclude":[209],"that":[210],"useful":[214],"endpoint":[215],"predicts":[219],"OS":[220],"not":[223,234],"associated":[224],"age.":[226],"Using":[227],"as":[229],"endpoint,":[231],"we":[232],"did":[233],"detect":[235],"benefit":[237],"any":[239],"strategy":[241],"than":[243],"ASCT.":[244]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-12-21T00:00:00"}